Thonzylamine
 | |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| ATC code | D04AA01 (WHO) R01AC06 (WHO) R06AC06 (WHO) |
| Identifiers | |
| |
| Synonyms | Neohetramine |
| CAS Number |
91-85-0  N 63-56-9 |
| PubChem (CID) | 5457 |
| ChemSpider |
5258  Y |
| UNII |
R79646H5Z8 Y |
| KEGG |
D08587 Y |
| ChEMBL |
CHEMBL1623738 N |
| ECHA InfoCard | 100.001.913 |
| Chemical and physical data | |
| Formula | C16H22N4O |
| Molar mass | 286.372 g/mol |
| 3D model (Jmol) | Interactive image |
| |
| |
| NY (what is this?) (verify) | |
Thonzylamine (or neohetramine)[1] is an antihistamine and anticholinergic used as an antipruritic.
Synthesis
Thonzylamine synthesis: H. L. Friedman and A, V. Tolstouhov, U.S. Patent 2,465,865 (1949).
See also
References
| Antihistamines for topical use | |
|---|---|
| Anesthetics for topical use | |
| Others |
|
Decongestants and other nasal preparations (R01) | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Topical |
| ||||||||||||||
| Systemic use: Sympathomimetics | |||||||||||||||
| Aminoalkyl ethers |
|
|---|---|
| Substituted alkylamines | |
| Substituted ethylenediamines |
|
| Phenothiazine derivatives | |
| Piperazine derivatives | |
| Others for systemic use |
|
| For topical use | |
| Receptor (ligands) |
| ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Transporter (inhibitors) |
| ||||||||||||||
| Enzyme (inhibitors) |
| ||||||||||||||
| Others |
| ||||||||||||||
This article is issued from Wikipedia - version of the 4/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.